Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Weiler

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Phlebology|May 30, 2024
Safety of synchronous prophylactic ablation of the anterior saphenous vein in patients undergoing great saphenous vein thermal ablation- 6 months follow-up data of the SYNCHRONOUS studyCarmen K Dietrich, Tobias Hirsch, Karsten Hartmann, et al.
Phlebology|May 7, 2024
Compression therapy after endovenous laser ablation: Patient compliance and impact on clinical outcomeCarmen K Dietrich, Markus Stucker, Karsten Hartmann, et al.
Journal of Medicinal Chemistry|December 20, 1996
2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotidesR H Griffey, B P Monia, L L Cummins, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Phlebology|May 30, 2024
Safety of synchronous prophylactic ablation of the anterior saphenous vein in patients undergoing great saphenous vein thermal ablation- 6 months follow-up data of the SYNCHRONOUS studyCarmen K Dietrich, Tobias Hirsch, Karsten Hartmann, et al.
Phlebology|May 7, 2024
Compression therapy after endovenous laser ablation: Patient compliance and impact on clinical outcomeCarmen K Dietrich, Markus Stucker, Karsten Hartmann, et al.
Journal of Medicinal Chemistry|December 20, 1996
2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotidesR H Griffey, B P Monia, L L Cummins, et al.
Pageof 5